Epinephrine induces a late thromboxane-dependent platelet shape change and enhances synergistically the shape change induced by other platelet agonists

References

• O'Brien JR. Platelet stickiness. Ann Rev Med 1966; 17: 275–90
   PubMedGoogle Scholar
• Born GVR. Observations on the change in shape of blood platelets brought about by adenosine diphosphate. J Physiol 1970; 209: 487–511
   PubMed Web of Science ®Google Scholar
• Patscheke H, Wörner P. Platelet activation detected by turbidometric shape-change analysis. Thromb Res 1978; 12: 485–96, Differential influence of cytochalasin B and prostaglandin El
   PubMedGoogle Scholar
• Patscheke H. Correlation of activation and aggregation of platelets. Discrimination between anti-activating and anti-aggregating agents. Haemostasis 1979; 8: 65–81
   PubMedGoogle Scholar
• White JG. Platelet microtubules and microfilaments: effects of cytochalasin B on structure and function. Platelet Aggregation, J Caen. Masson, Paris 1971; 15–52
   Google Scholar
• Milton J G, Frojmovic M M. Adrenaline and adenosine diphosphate induced platelet aggregation require shape change. J Lab Clin Med 1984; 104: 805–15
   PubMedGoogle Scholar
• Estensen R D, White J G. Ultrastructural features of the platelet response to phorbol myristate acetate. Am J Path 1974; 4: 41–52
   Google Scholar
• Regan J W, De Marinis RM Nakatah, Caron M G, Lefkowitz R J. Purification and characterization of the human platelet alfa2-adrenergic receptor. J Biol Chem 1986; 261: 3894–97
   PubMedGoogle Scholar
• Thompson N T, Scrutton M C, Wallis R B. Synergistic responses in human platelets. Eur J Biochem 1986; 161: 399–408, Comparison between aggregation, secretion and cytosolic Ca2+ concentration.
   PubMedGoogle Scholar
• Connolly T M, Limbird L E. The influence of Na+ on the α2-adrenergic receptor system of human platelets. J Biol Chem 1983; 258: 3907–12, A method for removal of extraplatelet Na+Effect of Na+ removal on aggregation, secretion and c-AMP accumulation
   PubMedGoogle Scholar
• Motulsky H J, Shattil S J, Ferry N, Rozansky D, Insel P A. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the α2-adrenergic receptor or receptor coupling to adenylate cyclase. Mol Pharmacol 1986; 29;: 1–6
   PubMed Web of Science ®Google Scholar
• Jackson S P, Yuan Y, Schoenwaelder S M, Mitchell C A. Role of platelet integrin glycoprotein IIb-IIIa in intracellular signalling. Thromb Res 1993; 71: 159–68
   PubMedGoogle Scholar
• Nieuwland R, Wijburg OLC, Van Willigen G. Alfa-2A adrenergic receptors activate protein kinase C in human platelets via a pertussis toxin-sensitive G-protein. FEES Lett 1994; 339: 79–83
   PubMedGoogle Scholar
• Resink T I, Buhler F R. The influence of epinephrine on washed human platelets: shape change and protein phosphorylation. J Recept Res 1984; 4: 537–56
   PubMed Web of Science ®Google Scholar
• Nakano T, Terawaki A, Arita H. Signal transduction in collagen-stimulated rat platelets is composed of three stages. J Biochem 1987; 101;: 1169–80
   PubMedGoogle Scholar
• Keraly C L, Kinlough-Rathbone R L, Packham M A, Suzuki H, Mustard J F. Conditions affecting the responses of human platelets to epinephrine. Thromb Haemost 1988; 60: 209–16
   PubMedGoogle Scholar
• Piche L A, Mahadevappa V G. Aggregation and or oxygenated products of arachidonic acid are not required for collagen-induced deacylation of phosphatidylcholine in human platelets. Biochem J 1989; 263: 143–8
   PubMedGoogle Scholar
• Daniel J L, Molish I R, Rigmaiden M, Stewart G. Evidence for a role of myosin phosphorylation in the initiation of the platelet shape change response. J Biol Chem 1984; 259: 9826–31
   PubMed Web of Science ®Google Scholar
• Ware J A, Johnson P C, Smith M, Salzman E W. Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. J Clin Invest 1986; 77: 878–86
   PubMed Web of Science ®Google Scholar
• Siess W, Lapetina E G. Platelet aggregation induced by alfa 2-adrenoceptor and protein kinase C activation. Biochem J 1989; 263: 377–85, A novel synergism
   PubMed Web of Science ®Google Scholar
• Steen V M, Holmsen H, Aarbakke G. The platelet-stimulating effect of adrenaline through α2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. Thromb Haemost 1993; 70: 506–13
   PubMed Web of Science ®Google Scholar
• Goto S, Ikeda Y, Murata M, Handa M, Takahashi E, Yoshioka A, Fujimura Y, Fukuyama M, Handa S, Ogawa S. Epinephrine augments von Willebrand factor-dependent shear induced platelet aggregation. Circulation 1992; 86: 1859–63
   PubMed Web of Science ®Google Scholar
• Rinder C S, Student L A, Bonan J L, Rinder H M, Smith B R. Aspirin does not inhibit diphosphate-induced platelet a granule release. Blood 1993; 82: 505–12
   PubMed Web of Science ®Google Scholar
• Sano K, Takai Y, Yamanishi J, Nishizuka Y. A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. J Biol Chem 1983; 258: 2010–13
   PubMed Web of Science ®Google Scholar
• Haslam R J, Lynham J A. Relationship between phosphorylation of blood platelet proteins and secretion of platelet granule constituents. Biochem Biophys Res Commun 1917; 77: 714–22, IEffects of different aggregating agents
   Google Scholar
• Hathaway DR, Adelstein R S. Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity. Proc Natl Acad Sci USA 1979; 76: 1653–57
   PubMed Web of Science ®Google Scholar
• Figures W R, Scearce M, Wachtfogel Y, Chen J, Colman R F, Colman R W. Platelet ADP receptor and α2-adrenoceptor interaction. J Biol Chem 1986; 261: 5981–86
   PubMed Web of Science ®Google Scholar